Mr. Thiroloix will be responsible for leading and directing commercial activities in Europe, focusing on orthopedic and sports medicine products. He has experience with sales and marketing with various companies in Europe and most recently served as executive vice president of corporate development at global biopharmaceutical company Ipsen.
Related Articles on Orthopedic and Spine Devices:
More Insurance Companies Now Reimburse for TranS1’s AxiaLIF
Zimmer Signs Distribution Agreement for Benvenue Medical’s Vertebral Compression Fracture Treatment System
Stryker’s Net Earnings Decline, Acquisitions Save Sales Growth
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.